Adams Street Partners’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-490,707
| Closed | -$2.01M | – | 17 |
|
|
2017
Q4 | $2.01M | Sell |
490,707
-982,354
| -67% | -$4.03M | 0.48% | 8 |
|
|
2017
Q3 | $6.66M | Sell |
1,473,061
-366,669
| -20% | -$1.66M | 1.7% | 5 |
|
|
2017
Q2 | $6.13M | Hold |
1,839,730
| – | – | 1.44% | 6 |
|
|
2017
Q1 | $16.9M | Hold |
1,839,730
| – | – | 4.17% | 4 |
|
|
2016
Q4 | $14.2M | Hold |
1,839,730
| – | – | 3.9% | 5 |
|
|
2016
Q3 | $19.6M | Hold |
1,839,730
| – | – | 3.7% | 5 |
|
|
2016
Q2 | $22.6M | Hold |
1,839,730
| – | – | 3.71% | 5 |
|
|
2016
Q1 | $18.6M | Hold |
1,839,730
| – | – | 3.39% | 6 |
|
|
2015
Q4 | $41.5M | Buy |
1,839,730
+176,080
| +11% | +$3.97M | 7.46% | 4 |
|
|
2015
Q3 | $27.6M | Hold |
1,663,650
| – | – | 5.86% | 3 |
|
|
2015
Q2 | $37.4M | Hold |
1,663,650
| – | – | 5.63% | 4 |
|
|
2015
Q1 | $42.9M | Buy |
+1,663,650
| New | +$42.9M | 6.84% | 3 |
|